MS & Immune Disorders

Filter Your Results




Promising Results Published for Pembrolizumab to Treat Progressive Multifocal Leukoencephalopathy

Tuesday, April 16, 2019—As published in the New England Journal of Medicine, positive results have been seen in a small study of pembrolizumab (Keytruda; Merck, Kenilworth, NJ) for treatment of …

FDA Approves Cladribine Tablets—First and Only Short-Course Treatment for Relapsing-Remitting MS

Monday, April 01, 2019—The Food and Drug Administration (FDA) has approved cladribine tablets (Mavenclad; EMD Serono, Rockland, MA) for treatment of relapsing-remitting multiple sclerosis (RRMS) and…

Siponimod Approved by FDA for Treatment of Relapsing-Remitting and Secondary-Progressive Multiple Sclerosis

Wednesday, March 27, 2019—The first drug to treat 3 phases of multiple sclerosis (MS), secondary-progressive MS (SPMS), relapsing-remitting MS (RRMS), and clinically isolated syndrome (CIS), has b…

The Importance of Sleep

Logan Schneider, MD

March/April 2019—Sleep has a critical role in brain health and is an essential part of improving neurologic care for all of our patients.

Multiple Sclerosis Minute: Telemedicine and Multiple Sclerosis

Riley Bove, MD, MMSc; and Valerie J. Block, DPTSc, PT

March/April 2019—Telemedicine is acceptable to patients and clinicians in the continuum of clinic-to-in-home care and reduces barriers to care.

Dizziness and Vertigo

Ari A. Shemesh, MD; and Daniel R. Gold, DO

March/April 2019—Part 1: Untangling the complexity of dizziness and vertigo requires a careful history.

Patient’s Risk Tolerance for Disease Modifying Treatments for Multiple Sclerosis

Friday, March 15, 2019—In a study published in Neurology, researchers at the Cleveland Clinic evaluated patients’ tolerance for potential risks of multiple sclerosis (MS) medications. Stu…

Analysis of Cladribine Tablets Clinical Trials Continues to Support Safety and Efficacy

Thursday, March 07, 2019—In the 2-year CLARITY trial (NCT00213135), 47% of patients treated with cladribine tablets (CT) (EMD Serono; Rockland, MA) achieved no evidence of disease activity (NEDA) comp…


Contact Info

For advertising rates and opportunities:
Wendy Terry

About Practical Neurology

Launched in 2002, Practical Neurology is a publication uniquely dedicated to presenting current approaches to patient management, synthesis of emerging research and data, and analysis of industry news with a goal to facilitate practical application and improved clinical practice for all neurologists. Our straightforward articles give neurologists tools they can immediately put into practice.